Ureter Obstruction
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Double-J PLUS Postmarket Registry Study
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
Robot-Assisted Pyeloplasty in Young Children
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:
Is it Safe to Advance a Guidewire Through a Previously Placed Double j Stent?
Primary Versus Deferred Ureteroscopy for Calculus Anuria in Children